ThinkstockThe world’s second largest maker of laboratory equipment, Thermo Fisher Scientific Inc. (NYSE: TMO) has agree to acquire competitor Life Technologies Corp. (NASDAQ: LIFE) for $13.6 billion in cash ($76 a share).…
Jon OggThese are some of this Friday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Air Lease Corp. (NYSE: AL) named Bull of the Day as “earnings takeoff”…
ThinkstockThere are big movers in the market just about every day, and these movers often come from biotech and other emerging health care winners and losers. The daily direction of the broad…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research firms this Friday. Bank of New York Mellon Corp. (NYSE: BK) cut to Neutral at…
ThinkstockWe have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena Pharmaceuticals Inc. (NASDAQ: ARNA), Biogen Idec…
We have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ: ALXN), Amgen Inc. (NASDAQ: AMGN), Arena Pharmaceuticals Inc. (NASDAQ: ARNA), Biogen Idec…
The short interest in biotech stocks is mixed, judging by the short interest changes between the September 14 and September 28 settlement dates. There were notable swings in shares sold short from…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Friday. Applied Materials Inc. (NASDAQ: AMAT) maintained Buy with $16 target after layoffs…
Tuesday has two merger rumors out from reports today and the shares are surging on the news. We are seeing MetroPCS Communications Inc. (NYSE: PCS) and Illumina Inc. (NASDAQ: ILMN) on the run…
Jon C. Ogg With a couple of exceptions, the short interest in biotech stocks is on the rise again, judging by the short interest changes from September 14 settlement date versus the August 31 settlement…
The short interest in biotech stocks is generally falling, judging by the short interest changes from August 31 settlement date versus the August 15 settlement date. We have tracked the key short…
The short interest in biotech stocks is generally rising, judging by the short interest changes from August 15 settlement date versus the July 31 settlement date. We have tracked the key short…
The short interest data is out from the July 31 settlement date and, with a couple of notable exceptions, short sellers generally have retreated from their gambles on biotech firms. For the…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Friday. Celgene Corporation (NASDAQ: CELG) Maintained Buy with target of $73.00 at Cantor…
The major US stock indexes opened lower this morning following a weekend of elections in Europe. A new Socialist party president in France and a still very cloudy future in Greece have…
